I work out of our brand new facility in South San Francisco. The site, which launched earlier this year, is magnificent – it’s located in the Bay Area, which is a fantastic hub for biotech, and has lots of great amenities that make my life easier, including a cafeteria, a gym and snacks on every floor. On my way to my desk, I grab some hummus and crackers, then take my first call right around 9.
Today it’s a check in with the leaders of market access, the team I’m a part of here at AbbVie. We focus on the ecosystem that exists between the manufacturers that develop medications, and the pharmacies that dispense them to patients. Here, there are multiple players – from payers, to distributors, hospital systems, provider groups, pharmacy networks and more – who can facilitate or hinder the delivery of new treatments.
Our goal as a team is to remove bottlenecks within the ecosystem so patients can get the treatments their doctor feels is right for them with as much ease as possible. Specifically, my team supports our oncology patients. Timely access for them is often crucial, as delays can impact outcomes and how patients navigate care.
I joined market access about five years ago, following a career as a pharmacist. My interest in pharmacy and health care overall is really rooted in my own upbringing. I grew up as a refugee, moving from one country to the next, without any formal ties to the different communities or access to state systems or infrastructure. Access to health care was out of reach for many of us, unless we were connected to someone who could extend the privilege to us, and health literacy was generally very low. Seeing this as a kid, I used to think, if I knew more about the field and could help people navigate treatment, I could help a lot of people. It’s how I learned just how important health care access is.